Evgen Pharma (GB:EVG) has released an update.
Vulpes Investment Management Pte Ltd has altered their stake in Evgen Pharma PLC, with a notification of an acquisition or disposal of voting rights revealing a resulting situation of 4.81% total voting rights as of April 11, 2024. The change in holdings, involving direct voting rights associated with shares, crossed the notifiable threshold, with the company being informed on April 18, 2024. This financial move by Vulpes highlights a significant change in investor interest and potential impact on Evgen Pharma’s stock.
For further insights into GB:EVG stock, check out TipRanks’ Stock Analysis page.
